SpringerLink
Log in

Bildgebung bei pulmonaler Hypertonie

Imaging of pulmonary hypertension

  • Leitthema
  • Published:
Der Pneumologe Aims and scope

Zusammenfassung

Hintergrund

Die pulmonale Hypertonie (PH) ist eine hämodynamische Störung des Lungenkreislaufs mit einer pathologischen Erhöhung des pulmonalarteriellen Drucks.

Fragestellung

Dieser Beitrag gibt einen Überblick über die Bildgebung bei PH bei Erwachsenen und diskutiert deren Wert für die Erkennung einer PH, die Identifizierung der Ursache und die Beurteilung der Prognose.

Material und Methode

Es werden Grundlagenarbeiten, Leitlinien und Expertenempfehlungen diskutiert.

Ergebnisse

Charakteristische Bildbefunde können auf eine PH hinweisen und zur Identifizierung der Ursache der PH beitragen. Eine Reihe von bildbasierten Parametern hat prognostische Bedeutung. Bei der Abklärung einer PH wird ein strukturiertes Vorgehen für den Einsatz von Bildgebung empfohlen.

Schlussfolgerungen

Der sinnvolle Einsatz von Bildgebung ist unverzichtbar für Patienten mit vermuteter PH, insbesondere für die Identifizierung der Ursache der PH.

Abstract

Background

Pulmonary hypertension (PH) is a hemodynamic condition of the pulmonary circulation with an abnormal increase in pulmonary arterial pressure.

Objective

This article gives an overview of imaging in PH in adults and reviews its value for the detection of PH, the identification of the cause of PH and the prognostic assessment.

Material and methods

The basic literature, guidelines and expert recommendations are discussed.

Results

Characteristic imaging findings can identify PH and help in establishing the cause of PH. A number of imaging-based parameters have prognostic value. In the evaluation of suspected PH a structured approach for the use of imaging is recommended.

Conclusion

The meaningful use of imaging is pivotal for patients with suspected PH, particularly for establishing the cause of PH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Galiè N, Humbert M, Vachiery J‑L et al (2015) 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS): endorsed by: association for European paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT). Eur Respir J 46:903–975

    Article  PubMed  Google Scholar 

  2. Simonneau G, Montani D, Celermajer DS et al (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53(1):1801913. https://doi.org/10.1183/13993003.01913-2018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kiely DG, Levin D, Hassoun P et al (2019) EXPRESS: statement on imaging and pulmonary hypertension from the pulmonary vascular research institute (PVRI). Pulm Circ 9(3):2045894019841990. https://doi.org/10.1177/2045894019841990

    Article  CAS  PubMed Central  Google Scholar 

  4. Rengier F, Melzig C, Derlin T et al (2019) Advanced imaging in pulmonary hypertension: emerging techniques and applications. Int J Cardiovasc Imaging 35:1407–1420

    Article  PubMed  Google Scholar 

  5. Remy-Jardin M, Ryerson CJ, Schiebler ML et al (2021) Imaging of pulmonary hypertension in adults: a position paper from the Fleischner society. Radiology 298:531–549

    Article  PubMed  Google Scholar 

  6. Truong QA, Massaro JM, Rogers IS et al (2012) Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography: the Framingham heart study. circ Cardiovasc Imaging 5:147–154

    Article  PubMed  Google Scholar 

  7. Lee SH, Kim YJ, Lee HJ et al (2015) Comparison of CT-determined pulmonary artery diameter, aortic diameter, and their ratio in healthy and diverse clinical conditions. PLoS ONE 10:e126646

    Article  PubMed  PubMed Central  Google Scholar 

  8. Rengier F, Wörz S, Melzig C et al (2016) Automated 3D Volumetry of the pulmonary arteries based on magnetic resonance angiography has potential for predicting pulmonary hypertension. PLoS ONE 11:e162516

    Article  PubMed  PubMed Central  Google Scholar 

  9. Melzig C, Wörz S, Egenlauf B et al (2019) Combined automated 3D volumetry by pulmonary CT angiography and echocardiography for detection of pulmonary hypertension. Eur Radiol 29:6059–6068

    Article  PubMed  Google Scholar 

  10. Johns CS, Kiely DG, Rajaram S et al (2019) Diagnosis of pulmonary hypertension with cardiac MRI: derivation and validation of regression models. Radiology 290:61–68

    Article  PubMed  Google Scholar 

  11. Swift AJ, Rajaram S, Hurdman J et al (2013) Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry. jacc Cardiovasc Imaging 6:1036–1047

    Article  PubMed  Google Scholar 

  12. Montani D, Achouh L, Dorfmüller P et al (2008) Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore) 87:220–233

    Article  Google Scholar 

  13. Tio D, Leter E, Boerrigter B et al (2013) Risk factors for hemoptysis in idiopathic and hereditary pulmonary arterial hypertension. PLoS One 8:e78132

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Jivraj K, Bedayat A, Sung YK et al (2017) Left atrium maximal axial cross-sectional area is a specific computed tomographic imaging biomarker of world health organization group 2 pulmonary hypertension. J Thorac Imaging 32:121–126

    Article  PubMed  Google Scholar 

  15. Aviram G, Rozenbaum Z, Ziv-Baran T et al (2017) Identification of pulmonary hypertension caused by left-sided heart disease (world health organization group 2) based on cardiac chamber volumes derived from chest CT imaging. Chest 152:792–799

    Article  PubMed  Google Scholar 

  16. Phillips JJ, Straiton J, Staff RT (2015) Planar and SPECT ventilation/perfusion imaging and computed tomography for the diagnosis of pulmonary embolism: a systematic review and meta-analysis of the literature, and cost and dose comparison. Eur J Radiol 84:1392–1400

    Article  CAS  PubMed  Google Scholar 

  17. Tunariu N, Gibbs SJR, Win Z et al (2007) Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 48:680–684

    Article  PubMed  Google Scholar 

  18. Dong C, Zhou M, Liu D et al (2015) Diagnostic accuracy of computed tomography for chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis. PLoS ONE 10:e126985

    Article  PubMed  PubMed Central  Google Scholar 

  19. Palm V, Rengier F, Rajiah P et al (2020) Acute pulmonary embolism: imaging techniques, findings, endovascular treatment and differential diagnoses. Rofo 192:38–49

    Article  PubMed  Google Scholar 

  20. Tamura M, Yamada Y, Kawakami T et al (2017) Diagnostic accuracy of lung subtraction iodine map** CT for the evaluation of pulmonary perfusion in patients with chronic thromboembolic pulmonary hypertension: Correlation with perfusion SPECT/CT. int J Cardiol 243:538–543

    Article  PubMed  Google Scholar 

  21. Masy M, Giordano J, Petyt G et al (2018) Dual-energy CT (DECT) lung perfusion in pulmonary hypertension: concordance rate with V/Q scintigraphy in diagnosing chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol 28:5100–5110

    Article  PubMed  Google Scholar 

  22. Rajaram S, Swift AJ, Telfer A et al (2013) 3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE registry. Thorax 68:677–678

    Article  PubMed  Google Scholar 

  23. Schönfeld C, Cebotari S, Voskrebenzev A et al (2015) Performance of perfusion-weighted Fourier decomposition MRI for detection of chronic pulmonary emboli. J Magn Reson Imaging 42:72–79

    Article  PubMed  Google Scholar 

  24. Lasch F, Karch A, Koch A et al (2020) Comparison of MRI and VQ-SPECT as a screening test for patients with suspected CTEPH: CHANGE-MRI study design and rationale. Front Cardiovasc Med 7:51

    Article  PubMed  PubMed Central  Google Scholar 

  25. Peacock AJ, Crawley S, McLure L et al (2014) Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study. circ Cardiovasc Imaging 7:107–114

    Article  PubMed  Google Scholar 

  26. Schoenfeld C, Hinrichs JB, Olsson KM et al (2019) Cardio-pulmonary MRI for detection of treatment response after a single BPA treatment session in CTEPH patients. Eur Radiol 29:1693–1702

    Article  PubMed  Google Scholar 

  27. Schoenfeld C, Cebotari S, Hinrichs J et al (2016) MR imaging-derived regional pulmonary parenchymal perfusion and cardiac function for monitoring patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy. Radiology 279:925–934

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Deutschland

    Fabian Rengier & Claudius Melzig

  2. Translational Lung Research Center (TLRC), Member of the German Center for Lung Research (DZL), University of Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Deutschland

    Fabian Rengier & Claudius Melzig

  3. Institut für Diagnostische und Interventionelle Radiologie, Medizinische Hochschule Hannover, Hannover, Deutschland

    Jens Vogel-Claussen

  4. Biomedical Research in End-stage and Obstructive Lung Disease Hannover (BREATH), Deutschen Zentrums für Lungenforschung (DZL), Medizinische Hochschule Hannover, Hannover, Deutschland

    Jens Vogel-Claussen

Authors
  1. Fabian Rengier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudius Melzig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jens Vogel-Claussen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fabian Rengier.

Ethics declarations

Interessenkonflikt

F. Rengier, C. Melzig und J. Vogel-Claussen geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Redaktion

S. Ley, München

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rengier, F., Melzig, C. & Vogel-Claussen, J. Bildgebung bei pulmonaler Hypertonie. Pneumologe 18, 307–313 (2021). https://doi.org/10.1007/s10405-021-00407-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-021-00407-z

Schlüsselwörter

Keywords

Search

Navigation